SCHEMBL1457263

SCHEMBL1457263

CC1CN(c2ncccc2Cl)CCN1C(=O)C1=NOC2(CCN(C(=O)Nc3ccc(C(C)(C)C)cc3)CC2)C1

nearest known ligand 0.60

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
TRPV1 Q8NER1 9/20 0.60
TRPA1 O75762 2/20 0.60
KCNH2 Q12809 1/20 0.60
TRPM8 Q7Z2W7 1/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5126118 0.89 TRPV1 (0.71) TRPV1TRPA1KCNH2TRPM8
SCHEMBL5116605 0.84 TRPA1 (0.42) TRPV1TRPA1
SCHEMBL4270033 0.82 TRPV1 (0.71) TRPV1TRPA1KCNH2TRPM8
SCHEMBL6432475 0.82 TRPV1 (0.71) TRPV1TRPA1KCNH2TRPM8
SCHEMBL2203441 0.82 GRM1 (0.46) TRPV1TRPA1
SCHEMBL2203446 0.82 GRM1 (0.46) TRPV1TRPA1
SCHEMBL5120202 0.81 TRPV1 (0.59) TRPV1TRPA1KCNH2TRPM8
SCHEMBL12512458 0.80 TRPV1 (0.41) TRPV1TRPA1
SCHEMBL5119085 0.80 TRPV1 (0.57) TRPV1TRPA1KCNH2TRPM8
SCHEMBL2208396 0.80 TRPV1 (0.66) TRPV1TRPA1KCNH2TRPM8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2292625-B1 SUBSTITUTED SPIRO COMPOUNDS AND THEIR USE FOR PRODUCING PAIN-RELIEF MEDICAMENTS GRUENENTHAL GMBH (DE) 2013-12-25 EP claimed
EP-2292625-A1 Substituted spiro compounds and their use for producing pain-relief medicaments Grünenthal GmbH (DE) 2011-03-09 EP claimed
US-20080214807-A1 Substituted Spiro Compounds and their Use for Producing Drugs GRUENENTHAL GMBH (DE) 2008-09-04 US claimed
EP-1893620-A2 SUBSTITUTED SPIRO COMPOUNDS AND THEIR USE FOR PRODUCING PAIN-RELIEF DRUGS Grünenthal GmbH (DE) 2008-03-05 EP claimed
WO-2006122769-A2 SUBSTITUTED SPIRO COMPOUNDS AND THEIR USE FOR PRODUCING PAIN-RELIEF DRUGS Grünenthal GmbH (DE) 2006-11-23 WO claimed
EP-2292625-B1 SUBSTITUTED SPIRO COMPOUNDS AND THEIR USE FOR PRODUCING PAIN-RELIEF MEDICAMENTS GRUENENTHAL GMBH (DE) 2013-12-25 EP disclosed
EP-2292625-A1 Substituted spiro compounds and their use for producing pain-relief medicaments Grünenthal GmbH (DE) 2011-03-09 EP disclosed
US-20080214807-A1 Substituted Spiro Compounds and their Use for Producing Drugs GRUENENTHAL GMBH (DE) 2008-09-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080214807-A1 Substituted Spiro Compounds and their Use for Producing Drugs REN, PKD1, NR3C2 TRPV1 675/4885TRPA1 720/4885KCNH2 866/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.